Skip to main content
BIONIME logo

BIONIME — Investor Relations & Filings

Ticker · 4737 ISIN · TW0004737002 TW Manufacturing
Open in API
Filings indexed 1,735 across all filing types
Latest filing 2024-05-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 4737

About BIONIME

www.bionime.com

Bionime Corporation is a biotechnology firm specializing in the research, design, and manufacturing of comprehensive blood glucose management systems. The company develops high-precision monitoring solutions for both personal home use and professional medical environments, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring Systems (CGM), and Point-of-Care Testing (POCT). Under its proprietary brand, RIGHTEST, Bionime integrates medical, chemical, electronic, and precision machinery expertise to deliver products that rival international standards. A core component of its offering is a cloud-based management ecosystem powered by IoT digital solutions, which synchronizes medical data with patient care services. With over 480 core patents in CGM technology and a commitment to Industry 4.0 smart production, Bionime focuses on enhancing diabetes care through technical innovation and a human-centered approach to health monitoring.

Recent filings

Filing Released Lang Actions
113年第1季綜合損益表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated comprehensive income statement for the first quarter of the year 113 (which corresponds to 2024 in the Taiwanese calendar). It includes detailed financial data such as revenue, costs, expenses, net profit, and earnings per share for the quarter ending March 31, 2024, compared to the same period in the previous year. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year indicates this is an Interim / Quarterly Report. The document length is 2301 characters, which is sufficient to contain financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2024-05-10 Chinese
113年第1季資產負債表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated balance sheet with detailed financial data for multiple periods, including specific dates (e.g., 113年03月31日, which corresponds to the first quarter of 2024). It includes comprehensive financial statement items such as assets, liabilities, and equity. The document length is 3872 characters, which is under 5000 characters, but it contains actual financial data rather than just an announcement or a link to a report. The content is consistent with an Interim / Quarterly Report (IR) because it covers a period shorter than a full fiscal year (the first quarter). There is no indication that this is a full annual report (10-K) or just an announcement. Therefore, the classification is Interim / Quarterly Report (IR).
2024-05-10 Chinese
113年4月營業收入
Fund Information / Factsheet Classification · 95% confidence The document is a brief financial summary report showing monthly and cumulative net operating revenue figures for a company named 華廣 for the period 民國113年04月 (April 2024). It includes percentage changes compared to the previous year and explanations for revenue changes. The document is very short (788 characters) and contains no detailed financial statements or comprehensive analysis. It is essentially a factsheet or summary of key financial data rather than a full report or announcement of a report publication. Therefore, it fits best into the category of Fund Information / Factsheet (FS).
2024-05-09 Chinese
113年4月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a company named 華廣, providing information about the absence of fund loans and endorsement guarantees for the current and previous months, as well as cumulative amounts and limits. The content is very short (601 characters) and consists mainly of tabular data about financial guarantees and loans, without detailed financial statements or analysis. There is no indication of it being a full financial report, audit, or management discussion. It appears to be a regulatory disclosure or compliance announcement related to financial guarantees and loans, typical of a general regulatory filing. Given the short length and nature of the content, it does not qualify as a full report but rather a regulatory announcement or filing.
2024-05-09 Chinese
公告本公司董事會通過113年度第一季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (華廣) reporting the board's approval of the consolidated financial report for the first quarter of the fiscal year 113 (which corresponds to 2024). It includes specific financial data for the period 113/01/01 to 113/03/31 (January 1 to March 31), such as revenue, gross profit, operating loss, net loss, total assets, liabilities, and equity. The document is short (907 characters) and contains substantive financial data and analysis for a quarterly period. This matches the definition of an Interim / Quarterly Report (IR). It is not merely an announcement of a report publication or a certification, but actual financial results are presented. Therefore, the correct classification is IR with high confidence.
2024-05-09 Chinese
113年04月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tabular data about shareholdings and pledged shares of company insiders, including directors, independent directors, and senior management. It lists their current holdings, pledged shares, and related percentages. The content focuses on insider share transactions and holdings rather than financial results, management changes, or meeting materials. There is no indication of a report publication or announcement, nor is there any financial statement or earnings data. The document is a disclosure of insider shareholdings and pledges, which aligns with the definition of Director's Dealing (DIRS) filings, which report personal share transactions by company directors and executives. The document length is 3194 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement. Therefore, the most appropriate classification is DIRS.
2024-05-03 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.